Beta-Glucan in Korean K-Beauty: A 2026 ODM Sourcing Brief for Indie Founders

By the ALTA MEET editorial team | K-beauty ODM consulting

Every few years a Korean ODM starts quietly rotating one ingredient onto more indie briefs than the previous quarter. In 2026 that ingredient is beta-glucan. It sits inside barrier repair serums, cushion compact essences, sun sticks, and the calming half of a bakuchiol dual-ampoule kit. It is not a new molecule. The Wollina, Pillai, and Röding 2005 paper in the International Journal of Cosmetic Science already showed measurable wrinkle-depth reduction after eight weeks of topical use at a 0.5 percent solution (source). What has changed is that Korean ODMs now have production experience with several structurally distinct beta-glucan grades, and indie founders are starting to specify the wrong one on RFQs. This brief walks through what the molecule actually is, what the published literature actually shows, what a Korean ODM needs on your brief, and where the sourcing traps are.

What Beta-Glucan Actually Is: The Two Structural Families Founders Should Know

Beta-glucan is a polysaccharide made of glucose units linked together. The way those units are linked, and where the branch points sit, is what separates one grade from another. There are two structural families that show up in cosmetic supply chains.

The first family is oat and cereal beta-glucan. Its glucose units are connected by beta-1,3 and beta-1,4 linkages in a linear chain. Because the chain is linear, oat beta-glucan is more water-soluble and generally has lower molecular weight variability than yeast-derived grades (review). Oat beta-glucan is the cheaper of the two and is the grade you will see most often in mass-market Korean sheet masks.

The second family is yeast and mushroom beta-glucan. Its glucose units are linked by beta-1,3 and beta-1,6 bonds, with the beta-1,6 side chain producing a branched three-dimensional structure. Yeast-derived material is typically less water-soluble at higher molecular weights, which is exactly why formulators use it: the branching profile is what has been associated with the Dectin-1 receptor binding that appears in the topical research literature (source). Yeast-derived beta-glucan is the grade Korean ODMs pull when a brand wants a barrier-repair claim rather than a straight humectant claim.

If your ODM quotes you a beta-glucan serum without telling you which of these two families it is using, the quote is incomplete. The molecular weight range and the source are the two spec lines that decide what your finished product actually does on skin.

What the Published Research Actually Shows About Topical Beta-Glucan

Anyone building a barrier repair claim on beta-glucan should be able to point to the source literature. The three publications that come up most in ODM technical dossiers are the 2005 Wollina paper cited above, a 2020 metabolic and immunomodulatory review in Nutrients, and a 2025 topical application review in Food Science & Nutrition.

The Wollina 2005 study enrolled 27 subjects and used a 0.5 percent beta-glucan solution dosed at 5 mg per square centimeter. Digital image analysis of silicone skin replicas showed a statistically significant reduction in wrinkle depth, height, and overall roughness after eight weeks (source). The subject count is small, so this is best treated as a proof-of-concept rather than a definitive claim. What it does is establish that beta-glucan, despite its molecular size, penetrates far enough into the epidermis to matter. That is not intuitive for a polysaccharide of this weight, which is part of why the paper still gets cited.

The 2020 Nutrients review pulls together the mechanistic work on Dectin-1 signaling, which is the pathway most commonly invoked in barrier repair claims (source). The 2025 Feng review in Food Science & Nutrition is the most recent open-access synthesis of the topical use case and is worth linking in your product page footer for search-visibility reasons alone (source).

A note on what the literature does not say. Beta-glucan does not have peer-reviewed evidence for pigment lightening, acne reduction on its own, or wrinkle reversal comparable to a retinoid. If your ODM proposes marketing copy in any of those directions, ask for the source paper before you sign off.

Concentration and Grade: What EU CosIng and Cosmetic Formulators Reference

The EU CosIng database lists beta-glucan under CAS 26874-89-5 with COSING reference 54744, categorized as a skin conditioning and bulking agent (source). CosIng does not impose an upper concentration cap on beta-glucan, which is why formulators reference published clinical work and vendor technical data sheets rather than a regulatory ceiling.

Cosmetic formulator guidance from ingredient distributors typically references a working range of one to five percent in leave-on products, with the Wollina protocol at 0.5 percent used as the floor for a barrier or wrinkle claim. Sheet mask essences often sit at the lower end because the essence stays on skin for fifteen minutes rather than eight hours. Ampoules and serums that carry a headline claim usually sit toward the upper end of that range.

Grade is a separate axis from concentration. Yeast-derived beta-glucan grades in commercial supply typically have average molecular weights in the range of roughly six to thirty kilodaltons for cosmetic use, with higher molecular weight grades used for medical wound-care formulations. Oat beta-glucan grades span a wider molecular weight range and vary by starch removal step in processing. When your ODM sends a technical data sheet, look at three lines: source organism, average molecular weight, and purity as a percentage of the dry solids.

Beta-Glucan in the Korean Cosmetic Regulatory Frame

South Korea regulates cosmetics through the Ministry of Food and Drug Safety under the Cosmetics Act. The country uses a negative list approach for cosmetic ingredients, meaning that if a substance is not on the prohibited list and is not on the restricted list with a specified upper limit, it is permitted for use in cosmetics manufacturing (source). Beta-glucan is not on either list, so it is a general-use cosmetic ingredient in Korea.

The functional cosmetic designation is separate. Korea maintains a specific list of notified functional ingredients in the Standards and Testing Methods of Functional Cosmetics. If an ingredient is on that list and used within the specified concentration for a designated functional purpose, a founder can file a notification rather than a full pre-market evaluation. Beta-glucan is not currently on that notified functional list, which means a beta-glucan product marketed with a general skin-conditioning claim in Korea can ship as a general cosmetic. If a founder wants to sell it as a functional wrinkle-improvement product in Korea, they need to submit a full pre-market evaluation dossier to MFDS.

Most US indie founders selling internationally will keep the claim on the general-cosmetic side to avoid the functional-cosmetic dossier work. The relevant compliance question shifts to the US MoCRA registration and the EU CPNP notification. Both of those pathways treat beta-glucan as an unremarkable general-use ingredient with no special dossier requirement.

Where Beta-Glucan Fits in a K-Beauty Formulation (and Where It Shouldn't)

Beta-glucan behaves like a large humectant with a soothing profile. It draws water into the upper layers of the stratum corneum, it slows transepidermal water loss when combined with occlusive lipids, and it plays well with fermented actives and centella extracts, which is why Korean ODMs often anchor barrier-repair briefs around it.

The formulation slots where it lands most often are recovery serums following an active step, post-procedure ampoules for aesthetic clinic partnerships, cushion essences designed for reapplication over makeup, and the calming half of a dual-ampoule kit paired with a stronger active like bakuchiol or retinal. It is also common in sun sticks and re-application sunscreen mists as a hydration cushion beneath the UV filters.

The slots where it does not fit as well are exfoliant-forward products, high-percentage acid tonics, and any product that needs to preserve a very low pH. Beta-glucan is stable across the standard cosmetic pH range but the sensory profile softens when it sits alongside a strong acid, which usually pushes formulators toward a different humectant like sodium PCA or glycerin in those slots.

The specific mistake worth flagging is stacking multiple large-molecule hydrators without a compensating lipid step. A product that combines beta-glucan, high molecular weight hyaluronic acid, polyglutamic acid, and Tremella extract can look impressive on a label but delivers less than the sum of its parts because the four molecules compete for surface hydration without addressing the barrier lipid layer. If beta-glucan is doing the heavy lifting on the barrier claim, the formula should include ceramides or a squalane-like emollient somewhere in the phase order.

A Founder Note from Manhattan

I'm Liz, I run altameet from Manhattan, NYC. Beta-glucan is one of those ingredients where the wrong RFQ line quietly costs indie founders a batch. If you have a brief in front of you and you are not sure whether you should be asking for oat or yeast beta-glucan, or what molecular weight range to specify, I'll give you a fifteen-minute gut check for free. It is faster than reading three more vendor data sheets. liz@altameet.com, or book a slot.

What a Korean ODM Needs on the Brief for a Beta-Glucan Serum

An indie founder brief that specifies beta-glucan should carry five lines that many first-time briefs leave out. The absence of these lines is what triggers the back-and-forth that adds two to three weeks to the sample cycle.

The first line is source. Yeast-derived (from Saccharomyces cerevisiae or a similar strain) or oat-derived, spelled out. If a founder writes beta-glucan without a source, the ODM picks the cheapest current-inventory grade, which is almost always oat, and the barrier claim in the marketing brief may or may not survive.

The second line is average molecular weight range or, if the founder does not have a target, a request for the ODM to quote at least two grade options with their molecular weight ranges disclosed. Korean ODMs will do this if asked, and comparing two grades side by side is what makes the sample round productive.

The third line is target concentration expressed as a percentage of the finished product. Most beta-glucan raw materials are supplied as one percent aqueous solutions rather than pure powder, so the founder needs to specify whether the target is percent of the finished formula or percent of active ingredient. Confusing these two numbers is one of the most common briefing errors and it inflates the raw material line on the quote by a factor of ten to one hundred.

The fourth line is claim strategy. Is this a barrier-repair headline claim, a soothing supporting-actor claim, or a hydration-humectant claim? The strategy decides which reference paper the ODM regulatory team will attach in the product dossier, which in turn decides which markets you can ship to without additional substantiation.

The fifth line is compatibility. Any other high-load humectant in the formula, any acid or exfoliant, any retinoid, any encapsulated actives. The ODM formulator needs the full ingredient stack because beta-glucan sensory behavior shifts depending on what shares the water phase with it.

Cost and Sourcing Signals to Watch Before You Sign a PO

Beta-glucan cost on a Korean ODM quote depends on three structural drivers rather than a single unit price. The first driver is source, since yeast-derived grades cost more per active kilogram than oat-derived grades because the extraction and purification workflow is longer. The second driver is molecular weight, since narrower molecular weight distribution grades require more processing and cost more. The third driver is the raw material format, since a stabilized aqueous one percent solution ships heavier and costs more to freight than a spray-dried powder.

The Korean ODM will usually add a small buffer for stability testing time when beta-glucan is a headline claim. This buffer reflects the extended stability testing needed to demonstrate that molecular weight has not degraded over the product shelf life, which is a legitimate concern with polysaccharide actives and one that founders should not push back on.

Two signals to watch. First, if a quote comes back with a beta-glucan line item that looks unusually low for the target concentration, ask the ODM whether the calculation was done on the aqueous solution basis rather than the pure active basis. A quote that treats a one percent aqueous solution as if it were pure active will look attractive on the spreadsheet and disappoint at the stability report. Second, if a founder is negotiating MOQ, beta-glucan raw material shelf life becomes a negotiation lever. Beta-glucan solutions typically hold twelve to eighteen months in sealed drums, so a smaller order that draws from a fresh drum will get a better molecular-weight profile than a smaller order that draws from the tail of a larger drum. Ask about drum age when you are negotiating a low-MOQ pilot batch.

Two Common Founder Missteps When Specifying Beta-Glucan

The first misstep is specifying beta-glucan for a product that already has a heavier active carrying the claim. A dual-ampoule kit with a bakuchiol side and a beta-glucan side works well because the two ingredients are in different bottles. Combining beta-glucan into the bakuchiol phase adds cost without adding claim substantiation and dilutes the sensory character of the retinol-alternative side. This is one of the reasons Korean ODMs quietly ask founders to reconfirm the intended architecture before locking the formula.

The second misstep is asking for a beta-glucan claim without asking for the molecular weight report. The molecular weight of the beta-glucan in a finished product is what most closely correlates with the published research outcomes. If the ODM cannot supply the average molecular weight of the beta-glucan raw material used in the batch, the founder cannot honestly reference the Wollina 2005 study or the 2025 Feng review in the product page copy. This is not a legal blocker but it is an editorial one, and the smarter indie brands are treating the molecular weight report as a required deliverable at ship-out rather than an optional attachment.

For a more general briefing template that covers these two missteps in the context of a full sample cycle, see our step-by-step Korean ODM briefing guide. The molecular weight discussion in the current post is the ingredient-specific overlay on that general template.

Key Takeaways

Beta-glucan is a general-use cosmetic ingredient in Korea, the EU, and the US with a small but real topical evidence base going back to a 2005 clinical study. It comes in two structural families, oat and yeast, and the two behave differently enough on skin that founders need to specify source on the brief. Working concentration for a leave-on product with a barrier or wrinkle claim usually sits between 0.5 and 5 percent. The five brief lines the ODM needs are source, molecular weight, target concentration in finished-product basis, claim strategy, and full compatibility stack. The two most common founder missteps are combining beta-glucan into a phase that already carries a stronger claim, and skipping the molecular weight report at ship-out. Cost drivers on the ODM quote are source, molecular weight distribution, and raw material format.

Frequently Asked Questions

Is beta-glucan a functional cosmetic ingredient under Korean MFDS rules?
Not currently. It is a general-use cosmetic ingredient under the negative list approach. A brand can market it as a general skin-conditioning or humectant ingredient in Korea without a functional cosmetic dossier. A wrinkle-improvement functional claim in the Korean market requires a full MFDS pre-market evaluation (source).

What is the difference between oat beta-glucan and yeast beta-glucan on a spec sheet?
Oat beta-glucan uses beta-1,3 and beta-1,4 linkages in a linear chain and is more water-soluble. Yeast beta-glucan uses beta-1,3 and beta-1,6 linkages in a branched three-dimensional structure and is where most of the barrier-signaling research has been done (source). For a barrier-repair claim, most Korean ODMs will suggest a yeast-derived grade.

What working concentration should indie founders specify for a beta-glucan serum?
Cosmetic formulator references typically place the working range at one to five percent in leave-on products. The Wollina 2005 clinical study used a 0.5 percent solution as the tested concentration for the wrinkle-depth outcome. Ampoules with a headline barrier or wrinkle claim usually sit toward the upper end of the range.

Does the Korean ODM need any special certifications for beta-glucan?
For general cosmetic use, no. Standard Korean ODM Good Manufacturing Practice certification, ISO 22716, and the usual raw material Certificate of Analysis package are sufficient. For a founder shipping into the EU, an INCI declaration and CPNP notification are required regardless of the ingredient, and beta-glucan is straightforward on both.

Can beta-glucan be combined with retinol or retinal in the same product?
Yes, at moderate concentrations. Beta-glucan is often used as the calming or soothing component alongside a retinol or retinal in a dual-phase or dual-ampoule kit. In a single-phase formula the concentration of beta-glucan usually needs to come down to avoid competing with the retinoid for the water phase, which is a formulation trade-off worth discussing with the ODM at the brief stage.

How much of a batch-to-batch molecular weight shift should a founder tolerate?
Ask the ODM for the specification range. A stable supply chain will typically hold molecular weight within a defined range across batches. What matters is that the range is disclosed on the finished-product Certificate of Analysis and matches the range in the technical data sheet the ODM referenced when quoting.

What internal altameet resources cover related topics?
For sample cycle mechanics, see the nine-step sample evaluation protocol. For the parent cost framework, see how much it costs to manufacture cosmetics in Korea.

Working With altameet

altameet is a Manhattan-based cross-border sourcing partner for US indie K-beauty founders. Founder Liz Song runs the practice out of the Upper East Side and works directly with Korean ODM partners in Seoul. If you are drafting a beta-glucan brief and you want a second pair of eyes on the source, molecular weight, or concentration lines before you send it to a Korean ODM, Liz does free fifteen-minute gut-check calls. Reach us at liz@altameet.com, at partnerships@altameet.com, or beta glucanK-beautyKorean ODMindie founderingredient sourcingbarrier repair